Skip to main content

Day: August 15, 2022

Galaxy Gaming Reports Q2 2022 Financial Results

LAS VEGAS, Aug. 15, 2022 (GLOBE NEWSWIRE) — Galaxy Gaming, Inc. (OTCQB: GLXZ), a developer and distributor of casino table games and enhanced systems for land-based casinos and iGaming content, announced today its financial results for the quarter and six months June 30, 2022. Financial Highlights Q2 2022 vs. Q2 2021Revenue increased 20% to $5,676K Adjusted EBITDA increased 10% to $2,358K Net loss of $(1,116)K vs. net income of 550K1H 2022 vs. 1H 2021Revenue increased 28% to $11,595K Adjusted EBITDA increased 31% to $5,032K Net loss of $(1,130)K vs. net income of 639KBalance Sheet Changes (vs. December 31, 2021)Cash increased 7% to $17,250K Total long-term debt1 (gross) decreased to $59,868K from $60,500K Stockholders’ deficit increased to $(18,0297)K from $(17,286)KExecutive Comments “The second quarter of 2022 was...

Continue reading

Palisade Bio Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Quarter marked by initiation of Phase 3 study evaluating LB1148 for postoperative return of bowel function CARLSBAD, Calif., Aug. 15, 2022 (GLOBE NEWSWIRE) — Palisade Bio (Nasdaq: PALI) a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications (the “Company”), reported its financial results for the quarter ended June 30, 2022. Additionally, the Company provided a clinical program update for its lead asset in development, LB1148, an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery. Recent HighlightsEntered into an underwriting agreement on August 12, 2022 for public offering for expected gross proceeds of $12 million, bringing total equity funding to...

Continue reading

FOMO CORP. ANNOUNCES RECORD QUARTER; POSITIONED FOR ACCELERATED GROWTH

Chicago IL, Aug. 15, 2022 (GLOBE NEWSWIRE) — FOMO CORP. (US OTC: FOMC) announces record second quarter results driven by significant demand for interactive whiteboard and EdTech solutions from K12 schools in Ohio, Pennsylvania, and West Virginia. Additionally, the Company positioned its clean tech business for renewed growth and continued to explore strategic mergers, acquisitions and investments. Strong 2Q22 Results Illustrate Inflection Point in the Business In the second quarter ended June 30, 2022, on a consolidated basis, the Company generated revenues of $2.6 million up $2.515 million or 2,959% from $85,000 during the same period in 2021. During the six months ended June 30, 2022, on a consolidated basis, the Company generated $3.9 million top line, up $3.65 million or 1,460% from $250,000 during the prior year’s same period....

Continue reading

InterCure Reports Record Breaking Second Quarter Financial Results

Rapid Revenue and EBITDA Growth Rapid Revenue and EBITDA Growth by Half Year CAD millionsRecord revenue of over $37 millioni in the second quarter of 2022 Representing an annual run rate of $150 million Adjusted EBITDAiifor Q2 increased 90% YoY to $9 million Net income of $6 million for the Q2 of 2022 compared to $2 million in Q2 of 2021 Tenth consecutive quarter of profitable growth Eighth consecutive quarter of positive cash flow from operations $96 million cash on hand Revenue growth expected to continue in the third quarter and throughout 2022 NEW YORK and TORONTO and HERZLIYA, Israel, Aug. 15, 2022 (GLOBE NEWSWIRE) — InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (“InterCure” or the “Company”) is pleased to announce its financial results for the second quarter of 2022 and is pleased to provide shareholders...

Continue reading

QCI Releases Video of Landmark Moment in Quantum Computing

First Pure Quantum Solution of a Complex Commercial Problem with Over 3,800 Variables Addresses Quantum’s Ability to Solve Large Scale Problems Today LEESBURG, Va., Aug. 15, 2022 (GLOBE NEWSWIRE) — Quantum Computing Inc. (“QCI” or the “Company”) (NASDAQ: QUBT), a leader in accessible quantum computing, today shared a video demonstrating what it believes is a landmark achievement in the field. In the video, QCI CTO/COO William McGann reveals that the Company has solved a sensor optimization problem with over 3,800 variables including 500 constraints in just over six minutes. This achievement demonstrates the first full-quantum solution, delivering a feasible and optimal result that is superior to previous comparative classical and hybrid approaches. The video (linked here) also features Dr. McGann presenting data that shows full...

Continue reading

HeartCore Reports Second Quarter 2022 Financial Results

NEW YORK and TOKYO, Aug. 15, 2022 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (“HeartCore” or “the Company”), a leading software development company, today reported financial results for the second quarter ended June 30, 2022. Second Quarter 2022 and Recent Operational HighlightsGrew total number of global enterprise customers to 877 as of June 30, 2022. Launched “truRes-12K”, the world’s first 12k-compatible real-time 360° virtual reality camera. Released Robot Store, an e-commerce website that provides Robotic Automation Process (“RPA”) services to its Japanese enterprise-level customers. Launched the Human Resources Digital Transformation Development Service, to help implement and advance HR related digital transformation initiatives for its enterprise-level customers. Authorized a $3.5 million share repurchase program. Signed...

Continue reading

Bellerophon Provides Clinical Program Update and Reports Second Quarter 2022 Financial Results

WARREN, N.J., Aug. 15, 2022 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today provided a clinical program update and reported financial results for the second quarter ended June 30, 2022. “The Bellerophon team continues to advance our late-stage INOpulse® inhaled nitric oxide therapy platform for the treatment of fibrotic interstitial lung disease, or fILD, and pulmonary hypertension associated with sarcoidosis, or PH-Sarc,” said Naseem Amin, M.D., Chairman of Bellerophon’s Board of Directors. “Enrollment is steadily proceeding in our Phase 3 REBUILD study in fILD, which is evaluating the change in moderate to vigorous physical activity following treatment with INOpulse....

Continue reading

WaveDancer Releases Second Quarter 2022 Results

$500,000 of Revenue Recognized from Blockchain Platform Development as Company Nears Full Production; Revenue up 44% from First Quarter FAIRFAX, Va., Aug. 15, 2022 (GLOBE NEWSWIRE) — WaveDancer (NASDAQ: WAVD), reported its results for the second quarter ended June 30, 2022, which was characterized by continued investment in its software development team and strategic efforts focused on maintaining and growing profitability in the Company’s professional services work. The Company recognized significant revenues after achieving substantial project milestones on their key United States government contract to bring a blockchain-enabled supply chain and logistics platform into full production. WaveDancer CEO Jamie Benoit commented, “The various investments we have made in WaveDancer are helping establish a strong foundation for growth....

Continue reading

Inuvo Revenue Increases 79.3% Year-Over-Year to $22.7 Million for the Second Quarter of 2022

Inuvo management to host conference call at 10:00 AM ET today, Monday, August 15, 2022 LITTLE ROCK, Ark., Aug. 15, 2022 (GLOBE NEWSWIRE) — Inuvo, Inc. (NYSE American: INUV), a leading provider of marketing technology, powered by artificial intelligence (AI) that serves brands and agencies, today provided a business update, and announced its financial results for the second quarter ended June 30, 2022. Richard Howe, CEO of Inuvo, stated, “We had another exceptionally strong quarter as demonstrated by a 79.3% year-over-year increase in revenue to $22.7 million for the three months ended June 30, 2022. We also achieved a 77.4% year-over-year increase in revenue to $41.3 million for the six months ended June 30, 2022. Importantly, we have realized approximately 15% compounded quarterly growth rate over the two-year period between Q2...

Continue reading

Edible Garden Continues Organic Growth with Revenue Increasing 7.5% Year-Over-Year for the Second Quarter of 2022 and New Expansion Initiatives Underway

Conference Call to Be Held Today at 11:00 am ET BELVIDERE, N.J., Aug. 15, 2022 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic, and sustainable produce, today provided a business update and reported financial results for the three months ended June 30, 2022. Mr. Jim Kras, Chief Executive Officer of Edible Garden, commented, “We continue to gain traction in the market, as evidenced by our solid year-over-year and sequential revenue growth, which does not reflect the deployment of the capital raised through our successful initial public offering (IPO) and listing on the Nasdaq in the second quarter. We are in the early stages of prudently deploying the capital, which we believe will help us further...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.